Rodrigo Naves

T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis

Robert C. Axtell, Brigit A. de Jong, Katia Boniface et al. · Nature Medicine · 2010 · 530 citations · Full text

Cells Determine Efficacy, Autoimmune Disease, Adaptive Immune System +13

Tuberculosis and impaired IL-23–dependent IFN-γ immunity in humans homozygous for a common <i>TYK2</i> missense variant

Stéphanie Boisson‐Dupuis, Noé Ramirez‐Alejo, Zhi Li et al. · Science Immunology · 2018 · 200 citations · Full text

Th1 and Th17 Cells and Associated Cytokines Discriminate among Clinically Isolated Syndrome and Multiple Sclerosis Phenotypes

Gabriel Arellano, Eric Acuña, Lilian I. Reyes et al. · Frontiers in Immunology · 2017 · 70 citations · Full text

Intranasal delivery of interferon-β-loaded nanoparticles induces control of neuroinflammation in a preclinical model of multiple sclerosis: A promising simple, effective, non-invasive, and low-cost therapy

Luis F. González, Eric Acuña, Gabriel Arellano et al. · Journal of Controlled Release · 2020 · 68 citations

Nanoparticles, Nanomedicine, Cell-based Drug Delivery +11

The Interdependent, Overlapping, and Differential Roles of Type I and II IFNs in the Pathogenesis of Experimental Autoimmune Encephalomyelitis

Rodrigo Naves, Simer Preet Singh, Kevin S. Cashman et al. · The Journal of Immunology · 2013 · 63 citations · Full text

Immunology, Immune Regulation, Innate Immunity +31